Friday 7/28 Insider Buying Report: SRPT, ETFC Friday, July 28, 10:48 AM ET
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Sarepta Therapeutics (SRPT), a filing with the SEC revealed that on Thursday, CEO Douglas S. Ingram bought 47,058 shares of SRPT, at a cost of $42.50 each, for a total investment of $2M. Bargain hunters are able to snag SRPT at a price even lower than Ingram did, with shares changing hands as low as $39.82 at last check today which is 6.3% below Ingram's purchase price. Sarepta Therapeutics is trading up about 0.1% on the day Friday. This purchase marks the first one filed by Ingram in the past year.
And on Tuesday, Director James P. Healy bought $209,855 worth of E*Trade Financial (ETFC), buying 5,000 shares at a cost of $41.97 each. E*Trade Financial Corporation is trading up about 0.1% on the day Friday. Investors are able to grab ETFC even cheaper than Healy did, with the stock trading as low as $40.50 in trading on Friday -- that's 3.5% under Healy's purchase price.
For MarketNewsVideo.com, I'm Sayoko Murase.
|